IN

Inotiv

NOTVQ
NASDAQHealth Care
$0.05
USD
-0.00(-9.80%)
At close: Jun 12, 20:00 UTC

Open

$0.08

Prev. Close

$0.08

High

$0.08

Low

$0.08

Market Snapshot

EPS

-4.61

Revenue

$475.11M

About

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,945 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Recently from Cashu

Couldn't load Cashu news

Something went wrong. Try refreshing the page.